opioid crisis

Showing 15 posts of 81 posts found.


Specialists petition FDA over opioid approval process

March 22, 2019
Medical Communications FDA, approval process, opioid crisis, opioids, painkillers

FDA officials have called on the federal agency to halt the approval of new narcotic painkillers. Dr Sidney Wolfe, a …

Tate art galleries will not accept donations from Sacklers

March 22, 2019
Medical Communications OxyContin, Purdue Pharma, Sacklers, Tate, art galleries, opioid crisis

The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the …


FDA Commissioner Scott Gottlieb announces resignation

March 6, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, opioid crisis, pharma

Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with …


OxyContin drugmaker Purdue Pharma exploring bankruptcy, sources say

March 4, 2019
Manufacturing and Production Litigation, Purdue Pharma, bankruptcy, opioid crisis, trials

OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces …


Head of opioid advisory panel criticises FDA for complacency in ongoing crisis

January 28, 2019
Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …


Sacklers accused of personally directing deceptive OxyContin sales tactics

January 17, 2019
Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …

FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone

December 12, 2018
Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma

Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …


FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics

December 11, 2018
Manufacturing and Production, Sales and Marketing FDA, Novartis, Pear Therapeutics, app, opioid crisis, opioid epidemic, opioids, pharma, reSET-o

A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app …


European Commission approves first and only long-acting opioid dependence therapy

November 26, 2018
Sales and Marketing Europe, opioid crisis, opioids, pharma

Europe has seen its first and only approval of a long-acting therapy for opioid dependence, as the European Commission (EC) …


Opioid use disorder market to hit $4.8 billion by 2027, says GlobalData

November 26, 2018
Sales and Marketing US, opioid crisis, opioids, pharma

New findings released by analytics firm GlobalData indicates that the market for opioid use disorder therapies is set to grow …


Opioid dependency therapy price hiked 600% since 2014, Senate investigators find

November 20, 2018
Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma

Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …


FDA commissioner Scott Gottlieb says that more rigorous approval process would be unique to opioids

November 12, 2018
Sales and Marketing FDA, Gottlieb, opioid crisis, opioids

Food and Drug Administration (FDA) commissioner Scott Gottlieb has said that if a more rigorous approval process is introduced for …

FDA controversially approves potent opioid up to ten times stronger than fentanyl

November 6, 2018
Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma

Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …


Trevena’s opioid injection fails to win over FDA committee

October 12, 2018
Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …

Latest content